Combining best-in-class AI-powered Technologies for Musculoskeletal (MSK) Imaging Workflows – ImageBiopsy Lab and Radiobotics sign Collaboration Agreement

Our Bureau

ImageBiopsy Lab (Vienna, Austria) and Radiobotics (Copenhagen, Denmark) have teamed up to advance the use of Artificial-Intelligence (AI) supported disease diagnostics for musculoskeletal (MSK), orthopaedic, and trauma use-cases in the DACH region. Globally, musculoskeletal conditions affect a larger population than circulatory or respiratory disorders. Despite this, diagnostic methods often remain […]

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

Our Bureau

MicuRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today announced that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) and the Fast Track Designation under the Generating Antibiotic Incentives Now (GAIN) Act […]

Life Time Expands to Connecticut with First Athletic Country Club and Life Time Living Luxury Residences in Downtown Stamford

Our Bureau

Life Time (NYSE:LTH), the nation’s premier healthy lifestyle brand, today opened its first athletic country club in Connecticut with a nearly 52,000-square foot athletic country club and 10,000-square-foot rooftop beach club in downtown Stamford. The vertically integrated tower featuring 290 luxury residences for lease also opened, licensed under the Life […]

United Imaging Healthcare debuts Next-Generation PET/CT Systems, the uMI Panorama Family, and the Integrated Molecular Technology Platform at EANM

Our Bureau

United Imaging Healthcare, a global leader in advanced medical imaging and radiotherapy equipment, introduces its next-generation PET/CT systems, the uMI Panorama™, and the integrated molecular technology platform named uExcel, at the European Association of Nuclear Medicine (EANM) 2023 annual meeting taking place from September 9-12 in Vienna, Austria. As the […]

Ion Channel Drug Developer Maxion Therapeutics Appoints Eva-Lotta Allan as Chair of its Board of Directors

Our Bureau

Today, Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announced the appointment of senior industry leader Eva-Lotta Allan as the Chair of its Board of Directors. The announcement comes at an important moment of growth by the company as it advances […]

New Report: Rates of Adult Obesity Continue to Climb, Particularly in Communities Experiencing Barriers to Healthy Eating and Few Opportunities for Physical Activity

Our Bureau

The number of adults in the United States with obesity continues to climb according to a new report, State of Obesity 2023: Better Policies for a Healthier America, released today. The report, the 20th annual edition produced by Trust for America’s Health (TFAH), examines the root causes of the nation’s […]

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

Our Bureau

Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to discovering, developing, and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, today announced that a Phase I study of the best-in-class anti-CD24 antibody, ATG-031, has been approved by the Institutional Review Board (IRB) of […]

Interim report from clinical study: ColdZyme significantly reduces rhinovirus viral load and symptoms of sore throat

Our Bureau

The first results from an ongoing independent clinical study at the University of Kent, UK, show that ColdZyme® significantly reduces the viral load of rhinovirus, the predominant cause of the common cold. Additionally, participants who used ColdZyme experienced significantly less severe sore throat symptoms than those who used placebo. The […]

Subscribe Now